Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Medicis, Hyperion deal

MRX's Ucyclyd Pharma Inc. subsidiary granted Hyperion rights to research and develop GT4P to treat urea cycle

Read the full 177 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE